Study Validates Cervical Sample Test for Endometrial Cancer Detection
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Medical Diagnostic Laboratories’ approach blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Read MoreMonitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreThe system’s processing speed accommodates the needs of both small laboratories with many different sample types requiring rapid processing and large labs that process large batches.
Read MoreThe BD Cor system automatically performs the sample preparation and processing steps necessary to complete molecular assays, while decreasing manual user interactions.
Read MoreSome argue that cytology adds little to cervical screening efforts, prompting additional discussion on the contribution of cytology to screening protocols.
Read MoreThe New York State Department of Health has approved the performance of ThyraMir testing on samples presented via cytology slides, FFPE-fixed tissue specimens, or fine needle aspirates.
Read MoreWuhan University has joined with the Landing Med enterprise to create an international platform for Cloud-based cervical cancer screening.
Read MoreThe company now processes patient specimens prepared as formalin-fixed, paraffin-embedded samples.
Read MoreWHO prequalification recognizes the important role that the CareHPV test can have in screening women in emerging countries for HPV.
Read MoreWomen aged 21 to 65 benefit from screening, and the USPSTF recommends three strategies for screening women aged 30 to 65.
Read MoreGuidelines on diagnostic testing issued by the United States Preventive Services Task Force...
Read MoreImager guides cytology technicians to areas showing potential abnormal cells, and images slides in approximately 90 seconds.
Read MoreFast Track Diagnostics has expanded its comprehensive sexually transmitted infections portfolio by adding an array of human papillomavirus (HPV) tests.
Read MoreTo find out more about Quest’s new survey on sexually transmitted infections, CLP recently spoke with Damian P. Alagia III, MD, FACOG, FACS, medical director for women’s health at Quest Diagnostics.
Read MoreThe company’s human papillomavirus test detects 14 types of HPV from specimens collected for cervical cancer screening in the BD SurePath liquid-based cytology vial.
Read More